Washington Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Washington Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,793	Closed	-$2.33M	–	98
2019 Q1	$2.33M	Sell	20,793 -3,600	-15%	-$395K	2.63%	3
2018 Q4	$2.35M	Sell	24,393 -150	-0.6%	-$15.9K	2.73%	6
2018 Q3	$2.99M	Sell	24,543 -549	-2%	-$64.6K	2.87%	5
2018 Q2	$2.76M	Hold	25,092	–	–	2.83%	5
2018 Q1	$2.68M	Hold	25,092	–	–	2.69%	10
2017 Q4	$2.68M	Buy	+25,092	New	+$2.68M	2.68%	10

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Washington Capital Management's IBB Position: Q2 2019 in Review

Washington Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 20,793 shares — an estimated $2.33M sold.

Washington Capital Management first reported a position in IBB in Q4 2017 and held it in 6 quarters. The position peaked at $2.99M in Q3 2018. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

Washington Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
Washington Capital Management sold 20,793 iShares Biotechnology ETF shares in Q2 2019, an estimated $2.33M.
Washington Capital Management first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 6 quarters.
Washington Capital Management's iShares Biotechnology ETF position peaked at $2.99M in Q3 2018.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Washington Capital Management's 13F filing for Q2 2019, filed 7 Aug 2019.